Want to see IN:SUNPHARMA full AI Analyst Report?
Sun Pharmaceutical Industries Limited (SUNPHARMA) Income Statement
Sun Pharmaceutical Industries Limited Income Statement
Last quarter (Q1 2027), Sun Pharmaceutical Industries Limited's total revenue was $153.00B, an increase of 10.46% from the same quarter last year. In Q1, Sun Pharmaceutical Industries Limited's net income was $28.95B. See Sun Pharmaceutical Industries Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 584.62B | $ 525.78B | $ 484.97B | $ 438.86B | $ 386.54B | |
| $ 325.62B | $ 410.20B | $ 370.55B | $ 325.67B | $ 277.78B | |
| $ 190.08B | $ 132.05B | $ 126.30B | $ 106.63B | $ 94.87B | |
| Depreciation and Amortization | $ 29.38B | $ 25.75B | $ 25.57B | $ 25.30B | $ 21.44B |
| $ 183.40B | $ 151.81B | $ 130.77B | $ 118.36B | $ 103.00B | |
| $ 135.53B | $ 278.15B | $ 244.24B | $ 219.04B | $ 182.91B | |
| $ 15.10B | $ -140.78B | $ -133.75B | $ -125.44B | $ -138.27B | |
| $ 150.63B | $ 137.37B | $ 110.49B | $ 93.61B | $ 44.65B | |
| $ 114.79B | $ 109.29B | $ 95.76B | $ 84.74B | $ 32.73B | |
| Per Share Metrics | |||||
| Basic EPS | $ 47.80 | $ 45.60 | $ 39.91 | $ 35.32 | $ 13.64 |
| Diluted EPS | $ 47.80 | $ 45.60 | $ 39.91 | $ 35.32 | $ 13.64 |
| Weighted Average Shares Outstanding | 2.40B | 2.40B | 2.40B | 2.40B | 2.40B |
| Weighted Average Shares Outstanding (Diluted) | 2.40B | 2.40B | 2.40B | 2.40B | 2.40B |
Currency in INR